CI Price Prediction Next Week
Analysis and Insights
To predict the stock price of Cigna (CI) for the next trading week, we analyze both fundamental and technical factors.
Fundamental Analysis:
Cigna (CI) has a Strong Buy consensus among analysts, with a price target of $365.39, indicating significant upside potential. The company recently reported Q4 revenue of $65.68 billion, exceeding estimates, though earnings missed due to higher stop-loss medical costs. Management has announced a $6 billion increase in its share repurchase program, signaling confidence in its valuation.
Technical Analysis:
The stock is currently trading near the lower end of its 52-week range ($56.715 - $68.77). Key Fibonacci levels indicate a pivot point at $319.51, with resistance at $329.11 and $335.04, and support at $309.91 and $303.98. The MACD is bearish, but the RSI is around 40, suggesting potential oversold conditions.
Price Prediction and Recommendation:
Based on the analysis, the stock is expected to trade around $322 next week. Given the oversold conditions and positive news sentiment, a cautious Buy is recommended as the stock approaches support levels. However, be mindful of resistance at the Fibonacci levels.
CI Similar Chart Price Prediction
The price of CI is predicted to go up -1.08%, based on the high correlation periods with PNC. The similarity of these two price pattern on the periods is 95.95%.
CI
PNC
Down: -1.08%Similarity: 95.95%
CI Revenue Forecast
CI EPS Forecast
CI FAQs
What is CI revenue forecast for next quarter？
What is CI eps forecast for next quarter？
CI VS S&P500
Combining with Express Scripts gave Cigna more tools to help clients control their healthcare costs, and we see significant cross-selling opportunities across their respective books of business.
With its strong medical cost trend history and goal to reduce that trend to the low-single-digits, Cigna should be able to benefit from continued enrollment gains in the more profitable commercial segment.
Cigna's organic earnings growth prospects look solid both with and without capital-allocation activities, such as share repurchases.
CI Analyst's Forecast
David Macdonald
Truist Securities
Strong Buy
2025-02-04
Price Target
$390 → $375
Upside
+27.85%
Truist lowered the firm's price target on Cigna to $375 from $390 and keeps a Buy rating on the shares. The firm is adjusting its model after the company's Q4 earnings miss, also cutting its FY25 EPS view to $29.58 from $31.40 and its FY26 view to $33.10 from $35.14, the analyst tells investors in a research note.
Michael Wiederhorn
Oppenheimer
Buy
2025-01-31
Price Target
$400 → $375
Upside
+27.46%
Raj Kumar
Stephens & Co.
Buy
2025-01-31
Price Target
$410 → $380
Upside
+29.16%
